Search & Analyze
Popular Searches
Cohance Lifesciences Ltd.
Healthcare₹420.000.45%
24 Jul, 4:01 PM
CMP₹420.00
Mkt Cap₹16.16K Cr
P/E90.16
P/B4.13
ROE14.20%
52W High₹1,057.60
52W Low₹267.85
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
90.16
P/B Ratio
4.13
EV/EBITDA
35.29
Price/Sales
7.12
Dividend Yield (%)
0.00
EPS (TTM ₹)
4.68
Book Value (₹)
102.24
ROE (%)
14.20
ROCE (%)
18.44
ROA (%)
10.02
EBITDA Margin (%)
31.33
Net Profit Margin (%)
22.11
Debt/Equity
0.05
Current Ratio
2.34
Interest Coverage
28.85
Asset Turnover
0.45
Working Capital/Sales
2.45
Core EBITDA Growth (%)
-7.26
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 100971.85 | 132022.21 | 134032.88 | 1051.35 | 1197.58 |
| Net Sales | 100971.85 | 132022.21 | 134032.88 | 1051.35 | 1197.58 |
| Total Income | 102395.55 | 141260.24 | 138669.26 | 1113.26 | 1256.14 |
| Total Expenditure | 56671.63 | 73850.02 | 76616.55 | 645.54 | 822.38 |
| Operating Profit | 45723.92 | 67410.22 | 62052.71 | 467.72 | 433.76 |
| Depreciation | 3163.58 | 3909.72 | 4798.64 | 54.6 | 77.49 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 46767.41 | 66758.98 | 55972.98 | 405.67 | 343.92 |
| Tax | 10533.23 | 21378.49 | 14843.95 | 105.39 | 79.15 |
| Profit After Tax (PAT) | 36234.18 | 45380.49 | 41129.03 | 300.28 | 264.77 |
| EPS (₹) | 14.23 | 17.83 | 16.16 | 11.8 | 10.52 |
| Dividend Payout % | 200 | 500 | 600 | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 2545.65 | 2545.65 | 2545.65 | 25.46 | 25.46 |
| Reserves | 115535.2 | 150172.39 | 170972.78 | 2023.24 | 1654.23 |
| Shareholders Funds | 118080.85 | 152718.04 | 173518.43 | 2050.67 | 1696.58 |
| Total Debt | 14122.85 | 9557.35 | 6916.2 | 38.58 | 78.13 |
| Total Liabilities | 157622.28 | 196681.33 | 211006.54 | 2254.1 | 3031.2 |
| Total Assets | 157622.28 | 196681.33 | 211006.54 | 2254.1 | 3031.2 |
| Book Value / Share | 46.3853 | 59.9918 | 68.1627 | 80.4674 | 65.9737 |
| Assets | 157622.28 | 196681.33 | 211006.54 | 2254.1 | 3031.2 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 38254.65 | 33000.02 | 45719.58 | 384.77 | 288.16 |
| Investing Activities | -31139.82 | -13613.83 | -19500.56 | -362.35 | -255.3 |
| Financing Activities | -7566.17 | -15648.07 | -24195.12 | -39.99 | 3.32 |
| Net Cash Flow | -451.34 | 3738.12 | 2023.9 | -17.57 | 36.18 |
COHANCE
₹420.00
+0.45%